Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 0 | 0 | 2,929 | 3,206 | 0 |
| Cost of Goods | N/A | N/A | 1,770 | 2,607 | N/A |
| Gross Profit | N/A | N/A | 1,159 | 599 | N/A |
| Operating Expenses | 611 | -5,880 | 2,666 | 2,406 | 871 |
| Operating Income | -611 | -255 | -737 | -1,200 | -871 |
| Interest Expense | 0 | 1,174 | 131 | 153 | 22 |
| Other Income | 30 | 27 | 0 | 0 | 0 |
| Pre-tax Income | -581 | -1,402 | -868 | -1,353 | -893 |
| Income Tax | N/A | N/A | N/A | N/A | 4 |
| Net Income Continuous | -581 | -1,402 | -868 | -1,353 | -897 |
| Net Income Discontinuous | N/A | -3,690 | N/A | N/A | -393 |
| Net Income | $-581 | $-5,092 | $-868 | $-1,353 | $-1,290 |
| EPS Basic Total Ops | -0.06 | -0.50 | -0.09 | -0.13 | -0.13 |
| EPS Basic Continuous Ops | -0.06 | -0.14 | -0.09 | -0.13 | -0.09 |
| EPS Basic Discontinuous Ops | N/A | -0.36 | N/A | N/A | -0.04 |
| EPS Diluted Total Ops | -0.06 | -0.50 | -0.09 | -0.13 | -0.13 |
| EPS Diluted Continuous Ops | -0.06 | -0.14 | -0.09 | -0.13 | -0.09 |
| EPS Diluted Discontinuous Ops | N/A | -0.36 | N/A | N/A | -0.04 |
| EBITDA(a) | $-601 | $6,303 | $-618 | $-1,138 | $-735 |